Next Article in Journal
Prevalence of Atypical Bacteria in Patients from Different Paediatric Age Groups Diagnosed with a Respiratory Disease
Previous Article in Journal
Expanded HPV Genotyping by Single-Tube Nested-Multiplex PCR May Explain HPV-Related Disease Recurrence
Previous Article in Special Issue
Potentially Pathogenic Vibrio spp. in Algal Wrack Accumulations on Baltic Sea Sandy Beaches
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Resistance in Lactococcus spp. Isolated from Native Brazilian Fish Species: A Growing Challenge for Aquaculture

by
Angélica Emanuely Costa do Rosário
1,
Angelo Carlo Chaparro Barbanti
1,
Helena Caldeira Matos
2,
Cynthia Rafaela Monteiro da Silva Maia
1,
Júlia Miranda Trindade
2,
Luiz Fagner Ferreira Nogueira
2,
Fabiana Pilarski
3,
Silvia Umeda Gallani
1,
Carlos Augusto Gomes Leal
2,
Henrique César Pereira Figueiredo
2 and
Guilherme Campos Tavares
2,*
1
Post-Graduate Program in Aquaculture, Nilton Lins University, Manaus 69058-030, AM, Brazil
2
Department of Preventive Veterinary Medicine, School of Veterinary Medicine, Federal University of Minas Gerais—UFMG, Belo Horizonte 31270-901, MG, Brazil
3
Laboratory of Microbiology and Parasitology of Aquatic Organisms, Aquaculture Center of Unesp, São Paulo State University (Unesp), Jaboticabal 14884-900, SP, Brazil
*
Author to whom correspondence should be addressed.
Microorganisms 2024, 12(11), 2327; https://doi.org/10.3390/microorganisms12112327
Submission received: 30 October 2024 / Revised: 12 November 2024 / Accepted: 13 November 2024 / Published: 15 November 2024
(This article belongs to the Special Issue Research on Diseases of Aquatic Organisms)

Abstract

:
Lactococcus spp. has emerged as a pathogen that is affecting global aquaculture, with L. garvieae, L. petauri, and L. formosensis causing piscine lactococcosis. While antimicrobials are commonly used to treat diseases in aquaculture, reports of antimicrobial resistance in fish isolates are increasing. However, little is known about the susceptibility patterns of Lactococcus spp. strains isolated from native fish species in Brazil. This study aimed to assess the antimicrobial susceptibility of these strains and establish a provisional epidemiological cutoff value for L. garvieae using the normalized resistance interpretation approach. A total of 47 isolates were tested: 17 L. garvieae, 24 L. petauri, and 6 L. formosensis. The isolates were classified as wild-type (WT) or non-wild-type (NWT) based on inhibition zone diameters. Isolates classified as NWT for three or more antimicrobial classes were considered multidrug-resistant, and the multiple antibiotic resistance (MAR) index was calculated. The results revealed heterogeneity in antimicrobial resistance profiles, with higher resistance to trimethoprim/sulfamethoxazole and norfloxacin. Resistance to other antimicrobials, including florfenicol and oxytetracycline (approved for use in Brazil), varied according to the bacterial species. Lactococcus petauri (87.5%) and L. formosensis (66.7%) showed the highest multidrug resistance, compared to L. garvieae (11.7%), along with higher MAR index values. These findings suggest that multidrug-resistant strains could pose future challenges in the production of native species, underscoring the need for ongoing monitoring of antimicrobial resistance and responsible use of antimicrobials in aquaculture.

1. Introduction

Piscine lactococcosis is considered an emerging bacterial disease for fish farming worldwide [1], and the number of hosts in which Lactococcus garvieae, L. petauri, and L. formosensis has been detected has expanded [2,3,4,5,6,7]. The disease is currently a significant health challenge for Oncorhynchus mykiss (O. mykiss) and Oreochromis niloticus (O. niloticus) production, causing high mortality rates and significant economic losses [8,9,10].
One of the main methods for controlling outbreaks of bacterial diseases in fish farms is antibiotic therapy [11]. Different classes of antimicrobials have been commonly used in global aquaculture, such as tetracyclines, phenicols, quinolones, β-lactams, macrolides, aminoglycosides, and sulfonamides. Each country has its own legislation governing the approval of antimicrobials for specific animal species, as well as regulations on the usage practices and allowable residue limits in animal-derived products [12]. However, none of these drug classes were developed exclusively for use in aquatic animals, and only a few antimicrobials are approved for use in this animal production sector [11]. For example, in Brazil, only oxytetracycline and florfenicol are permitted for use in aquaculture [13]. However, there are already reports of Lactococcus spp. strains becoming resistant to the main drugs used in aquaculture [14,15]. The indiscriminate use of antimicrobials has been reported by producers and technicians from different fish farms, which can result in bacterial resistance to specific drugs [16]. As a result, a product already used by a producer may no longer be effective in treating bacteriosis, thereby necessitating the use of another antibiotic. Additionally, it is worth mentioning that the rate of approval for new drugs is slower than the evolution of bacterial resistance, leading producers to use off-label drugs [17].
One way to monitor antimicrobial susceptibility in lactococcosis-causing bacteria is through the use of laboratory methods, such as disk diffusion [10] and broth dilution [18] methods. The former is considered an inexpensive, reliable, and simple technique that can be easily applied in a laboratory routine, while in comparison, the latter is technically demanding and labor-intensive [19]. However, in Brazil, few studies have evaluated these methodologies for testing Lactococcus spp. strains, whether using isolates from terrestrial mammals or aquatic animals. In Brazil, the disk diffusion assay has been performed for isolates of L. petauri from farmed O. niloticus, and resistance for some isolates to amoxicillin, erythromycin, florfenicol, and norfloxacin was identified. In addition, all the isolates evaluated were considered resistant to trimethoprim/sulfamethoxazole [10]. Bacteria of the genus Lactococcus have also been isolated from native Brazilian fish species [2], and little is known about the use of antimicrobials in these species and their antimicrobial susceptibility profiles.
The main problem in determining the sensitivity of bacterial fish pathogens to antimicrobials is the lack of reference values. Without these values, it is not possible to determine whether an isolate is sensitive or resistant. There are no internationally recognized epidemiological cutoff values for disk diffusion data for Lactococcus spp. strains in the Clinical Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. Previous studies have generated provisional epidemiological cutoff values for L. petauri from disk diffusion zone data using the normalized resistance interpretation (NRI) method [10] for L. garvieae and L. petauri from minimum inhibitory concentration data using NRI and ECOFFinder approaches [18]. Nevertheless, for disk diffusion zone data, there are no reports of established cutoff values in the literature for L. garvieae and L. formosensis.
Therefore, the aim of this study was to evaluate the susceptibility profile of L. formosensis, L. garvieae, and L. petauri strains obtained from native Brazilian fish species to different antimicrobials and to calculate the provisional epidemiological cutoff values (pECVs) for L. garvieae.

2. Materials and Methods

2.1. Bacterial Strains and Identification

A total of 47 Lactococcus spp. strains (n = 6 L. formosensis, n = 17 L. garvieae, and n = 24 L. petauri) were used in this study. The isolates were obtained from 11 native fish species (Arapaima gigas, Brycon amazonicus, Cichla sp., Colossoma macropomum, Hoplias macrophtalmus, Hoplias malabaricus, Lophiosilurus alexandri, Phractocephalus hemioliopterus, Pseudoplatystoma corruscans, Pseudoplatystoma fasciatum, and a hybrid of Pseudoplatystoma) originating from free-living fish or commercial farms, between 2012 and 2024, in 6 Brazilian states (Amazonas, Bahia, Mato Grosso do Sul, Minas Gerais, Pará, and São Paulo) (Table 1) [2,20,21,22,23,24]. These isolates were obtained through routine laboratory diagnosis of bacterial diseases in fish conducted by the Laboratory of Aquatic Animal Diseases (Veterinary School, Federal University of Minas Gerais, Belo Horizonte, Brazil), Laboratory of Applied Microbiology of Aquatic Organisms (Nilton Lins University, Manaus, Brazil), Laboratory of Microbiology and Parasitology of Aquatic Organisms (Aquaculture Center of São Paulo State University, São Paulo, Brazil), and Fisheries Institute (São Paulo, Brazil). Of these, 11, originating from Arapaima gigas (n = 7), Cichla sp. (n = 1), Hoplias malabaricus (n = 1), and Pseudoplatystoma sp. (n = 2), were recovered through bacterial examination after the recent disease outbreak. Furthermore, all the selected isolates were identified to species level using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (Bruker Daltonics, Bremen, Germany) [22] with the Bruker MALDI Biotyper database (v13.0.0.2), followed by gyrB sequencing [25]. The isolates were stored at −80 °C in BHI broth with 15% glycerol until use.

2.2. Susceptibility Testing

Disk diffusion tests against Lactococcus spp. were carried out according to the protocol provided in the CLSI guideline VET03, with adaptations recommended for bacteria of the genus Streptococcus (Group 4) [26]. The disks used contained 10 µg amoxicillin, 15 µg erythromycin, 30 µg florfenicol, 10 µg neomycin, 10 µg norfloxacin, 30 µg oxytetracycline, and 1.25/23.75 µg trimethoprim/sulfamethoxazole. The disks were obtained from a commercial company (Oxoid, Hampshire, UK).
The selected isolates (Table 1) were thawed, inoculated onto Man Rogosa & Sharpe (MRS, Merck, Darmstadt, Germany) agar, and incubated at 28 °C for 48 h. After incubation, colonies were collected and suspended in a sterile saline solution until they reached an absorbance of between 0.08 and 0.13 (DO625) nm using a spectrophotometer (Spectrum, Shanghai, China). Muller–Hinton agar enriched with 5% defibrinated sheep blood was inoculated with the bacterial suspension using sterile swabs. Then, antimicrobial disks were placed on the agar, and the plates were incubated at 28 °C for 24 h. Additionally, the quality control reference strains Escherichia coli ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658 were grown on blood agar, incubated at 28 °C for 24 h, and subjected to the same experimental conditions described above as recommended by the CLSI for this method. All the procedures were performed in duplicate. The diameter of the inhibition zone of all the isolates was measured.

2.3. Calculation of Provisional Lactococcus Garvieae Epidemiological Cutoff Values

As there is no established zone diameter cutoff for L. garvieae generated by a standard method, this study calculated the pECV for each antimicrobial agent tested using the automatic normalized resistance interpretation (NRI) method (www.bioscand.se/nri (accessed on 17 August 2024)) from the inhibition zone data that was generated [27,28]. The isolates were then classified as wild-type (WT) or non-wild-type (NWT) [29]. To meet the minimum requirements of the NRI method [30], the disk diffusion data of the L. garvieae strains isolated from O. niloticus (n = 3), Trichogaster lalius (n = 1), and Xiphophorus maculatus (n = 1) from the Laboratory of Aquatic Animal Diseases culture collection were included in the calculation of the pECVs (Table S2).

2.4. Data Analysis

Lactococcus petauri strains were classified as WT or NWT according to the previously established pECV [10]. However, as L. formosensis has no number of suggested observations to set a reliable pECV calculation, the inhibition zone data were shown as maximum, minimum, mean, and standard deviation values. Regardless of the bacterial species, bacteria that did not present an inhibition zone and did not have a defined ECV were considered not susceptible (NS) for the antimicrobials [31]. R software v.4.3.1 [32] and RAWGraphs v2.0 [33] were used for data visualization. Isolates classified as NWT for at least three classes of antimicrobials were considered to be multidrug-resistant bacteria [34]. The multiple antibiotic resistance (MAR) index was also calculated [35].

3. Results

3.1. Bacterial Identification

From the sequencing of the gyrB gene, Lactococcus formosensis (n = 1, Arapaima gigas), L. garvieae (n = 1, Cichla sp.; n = 1, Hoplias malabaricus; n = 1, Pseudoplatystoma sp.), and L. petauri (n = 6, Arapaima gigas; n = 1, Pseudoplatystoma sp.) were detected from the current disease outbreaks in native fish species (Table 1). The gyrB gene sequences of these isolates were included in the NCBI database.
The remaining isolates used in this study were identified at the species level in a previous study [2].

3.2. Quality Control

The reference strains E. coli ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658 presented inhibition zone diameters within the acceptable ranges established by the CLSI (Table 2).

3.3. Antimicrobial Susceptibility for Lactococcus formosensis

The disk diffusion assay for L. formosensis strains exhibited zones ranging between 6 mm and 30 mm (Table 2 and Table S1). All the isolates were categorized as NS (no observation of inhibition zone) for trimethoprim/sulfamethoxazole and norfloxacin (Figure 1). A total of one and four strains were categorized as NS for florfenicol and oxytetracycline, respectively (Figure 1). For these antimicrobials, all the isolates from A. gigas were categorized as NS for oxytetracycline, and the LG91-23 strain (from Pseudoplatystoma sp.) was NS for both drugs (Figure S1). Since there is no pECV for L. formosensis, it is not possible to determine whether the other isolates are resistant to other antimicrobials. In addition, four isolates were classified as multidrug-resistant. The MAR index of the isolates varied between 0.285 and 0.571 (Figure 2, Table S1).

3.4. Antimicrobial Susceptibility for Lactococcus garvieae

The disk diffusion assay for L. garvieae strains exhibited zones ranging between 6 mm and 31 mm (Table 2 and Table S1). The distribution of the inhibition zones obtained from all the evaluated isolates are shown in Figure S2. The calculated pECVs for the antimicrobials are presented in Table 2. A total of 8 and 15 isolates (Figure 1) presented a zone of complete inhibition of 6 mm for norfloxacin and trimethoprim/sulfametoxazole, respectively, preventing the establishment of the ECV for these antimicrobials. However, these isolates were categorized as NS. Based on the calculated pECVs, all the isolates were classified as WT for amoxicillin, erythromycin, and neomycin. One and five isolates were classified as NWT for florfenicol and oxytetracycline, respectively, especially those strains isolated from Pseudoplatystoma sp. (Figure S1). In addition, two isolates were classified as multidrug-resistant. The MAR index of the isolates varied between 0.00 and 0.428 (Figure 2, Table S1).

3.5. Antimicrobial Susceptibility for Lactococcus petauri

The disk diffusion assay for the L. petauri strains exhibited zones ranging between 6 mm and 31 mm (Table 2 and Table S1). All the isolates were classified as WT for neomycin. A total of 1, 8, 11, 22, 22, and 23 isolates were classified as NWT for amoxicillin, erythromycin, florfenicol, oxytetracycline, norfloxacin, and trimethoprim/sulfametoxazole, respectively (Table S1). A resistance phenotype for florfenicol and oxytetracycline was observed in all the native Brazilian fish species in which L. petauri was isolated (Figure S1). A total of 21 isolates were classified as multidrug-resistant. The MAR index varied between 0.285 and 0.857 (Figure 2, Table S1).

4. Discussion

Currently, antimicrobial resistance is one of the biggest threats to public health [36], especially with the emergence of multidrug-resistant strains [37]. The antimicrobial susceptibility profile in lactococcosis-causing bacteria strains has been studied by several different institutions and researchers using various techniques, such as disk diffusion [38,39], broth dilution [14,40], and the Etest [41]. Studies have suggested that most of the isolates evaluated are resistant to ampicillin [39,42], florfenicol [43], flumequine [38], nalidixic acid [42,44,45], norfloxacin [43], tetracycline [15], and trimethoprim/sulfamethoxazole [38,42,44,46]. Although detected at lower percentages, there are also records of resistance to amoxicillin (16–23%), bacitracin (42%), ciprofloxacin (4%), chloramphenicol (18%), enrofloxacin (33–67%), erythromycin (16–52%), kanamycin (33%), oxytetracycline (4–44%), and streptomycin (33%) [15,38,39,42,45,46].
In the scientific literature, it is possible to observe heterogeneity in the antimicrobial resistance profiles for Lactococcus spp. strains, which may be related to the different species within the genus. This is because most of the articles, including some recent ones, did not perform the correct taxonomic classification of the isolates, which is currently recommended [47]. Only three studies assessed the antimicrobial resistance profile after correct species identification, using disk diffusion [10,48] and broth dilution [18,49]. Furthermore, Öztürk et al. [18] suggest that this heterogeneity is related to the overuse or misuse of antimicrobials at the farm level and the lack of established susceptibility cutoff values for each of the three species that cause piscine lactococcosis. Here, we evaluated the antimicrobial resistance profiles of L. formosensis, L. garvieae, and L. petauri strains isolated from native fish species in Brazil using disk diffusion susceptibility testing and established pECVs for five out of seven antimicrobials for L. garvieae strains.
Regardless of the bacterial species evaluated in our study, the trimethoprim/sulfametoxazole resistance phenotype stood out (L. formosensis = 100%, L. garvieae = 88.2%, and L. petauri = 95.8%). Resistance to this drug has previously been reported in the literature for Lactococcus spp. strains isolated from O. mykiss, Dicentrarchus labrax, and O. niloticus [6,10,38,42,43,44,46]. For the other drugs, interspecies variation has been observed.
Unfortunately, due to the limited number of isolates identified as L. formosensis in our study, it was not possible to establish a pECV; therefore, classification as WT or NWT could not be performed. However, we considered those isolates for which no inhibition zones were observed for the antimicrobials tested to be NS. Thus, in addition to trimethoprim/sulfametoxazole, all the isolates were considered NS for norfloxacin. This result is in disagreement with the study conducted by Lin et al. [50], in which all the L. formosensis strains isolated from milk samples of a cow with clinical mastitis were susceptible to quinolones via broth dilution testing. We also did not observe the formation of inhibition zones in four isolates (three from A. gigas and one from Pseudoplatystoma sp.) for oxytetracycline, nor in one Pseudoplatystoma sp. isolate (LG91-23) for florfenicol. Chan et al. [48] evaluated susceptibility using the disk diffusion method for an L. formosensis strain obtained from a human with bacteremia and found that the isolate was susceptible to tetracycline. There is no mention in the literature regarding resistance profiles to florfenicol, regardless of the host evaluated; however, a previous study demonstrated resistance to another amphenicol, chloramphenicol, for all the isolates evaluated [50]. Although we cannot determine susceptibility for other drug classes, the literature mentions L. formosensis resistance to aminoglycosides and macrolides and susceptibility to β-lactams [48,50]. If we consider the pECV of L. garvieae and L. petauri from this study, all the isolates would be classified as WT for amoxicillin, erythromycin, florfenicol, and neomycin, which would corroborate the previous information. Additionally, the AM-LG05 strain would be classified as NWT for oxytetracycline, increasing the number of multidrug-resistant isolates. It was possible to observe that the antimicrobial resistance profile was similar among the A. gigas isolates, as all the isolates share the same geographic origin.
For the L. petauri strains, we compared the results using the previously established pECV. All the isolates evaluated were classified as WT for neomycin, thereby corroborating with Egger et al. [10]. For amoxicillin and erythromycin, our isolates demonstrated a low frequency of NWT detection, 4.1% and 33.3%, respectively, when compared to other antimicrobials. A previous study demonstrated resistance of 6% and 25% for L. petauri strains isolated from O. mykiss for erythromycin and amoxicillin, respectively [18]. For isolates obtained from O. niloticus, the NWT percentages were lower, around 3% for both antimicrobials [10]. A high percentage of isolates classified as NWT for norfloxacin was observed in our study (91.7%) compared to the results obtained in O. niloticus (16.75%) [10]. Regarding florfenicol and oxytetracycline, 11.4% and 91.6% of the isolates were classified as NWT, respectively. In O. mykiss and O. niloticus isolates, NWT values of 0% and 12.5% for oxytetracycline and 3.4% to 9.4% for florfenicol have been observed [10,18]. The resistance profile was similar among the Pseudoplatystoma sp. isolates from the states of Mato Grosso and Minas Gerais, as well as most of the A. gigas isolates from Bahia. However, for isolates obtained from this latter fish species in the northern region of Brazil, individual variation was detected, as were the cases with C. macropomum and B. amazonicus isolates.
There are no studies that have standardized cutoff values, even provisional ones, for L. garvieae strains following its correct taxonomic identification. Therefore, our study is the first to do so. However, we emphasize that the ECVs presented here are provisional. To generate ECVs that are relevant to disk diffusion data for L. garvieae, a larger number of isolates (over 100 observations) from at least 5 different laboratories would be required [30]. As previously mentioned, all the isolates evaluated were classified as being WT for amoxicillin, erythromycin, and neomycin. In contrast, isolates from O. mykiss exhibited varying susceptibility to these antimicrobials. Approximately 2.6%, 24.4%, and 6.4–11.5% of the isolates were resistant to amoxicillin, erythromycin, and aminoglycosides, respectively [18]. A total of 47% of the isolates from native fish species in Brazil were considered to be NS for norfloxacin, in contrast to previous studies that reported low (7.7%) or no resistance to quinolones [18,48]. A total of 5.8% and 29.4% of the isolates were classified as NWT for florfenicol and oxytetracycline, respectively. However, the literature reports resistance rates of 26.9% for florfenicol and 17.9% for oxytetracycline [18]. The antimicrobial resistance profile observed in our study for the L. garvieae strains was not consistent among the aquatic host species analyzed or with the origin of the isolates, demonstrating a heterogeneous profile.
Our study showed that the L. garvieae strains tend to be more sensitive to antimicrobials when compared to the L. formosensis and L. petauri strains. Furthermore, the proportion of L. garvieae isolates with a MAR index greater than 0.3 (11.7%) was lower than that found in L. formosensis (66.7%) and L. petauri (87.5%). The most efficient measure to control bacterial diseases is the use of antimicrobials [11]. However, since the isolates evaluated in this study were classified as multi-resistant to several antimicrobials, treating piscine lactococcosis in native Brazilian fish species becomes challenging. Unfortunately, little is known about the use of antimicrobials in native fish species in Brazil. However, prophylactic and metaphylactic use of antimicrobials, especially oxytetracycline, in larviculture of native species and during the feeding training of carnivorous species like Pseudoplatystoma sp. and A. gigas has been reported by producers and technicians in the country. Additionally, it is known that commercial fish farming in Brazil involves off-label use of amoxicillin, enrofloxacin, and norfloxacin [17,51]. In the central-western region of Brazil, fluoroquinolones, especially norfloxacin and enrofloxacin, intended for the treatment of cattle, have also been used off-label in Pseudoplatystoma sp. Therefore, the widespread use of these antimicrobials may have contributed to the increase in resistance among Lactococcus spp. strains. It is also worth mentioning that when MAR index values exceed 0.2 (in our case, over 0.3 due to the number of antibiotics tested), a high environmental risk of spreading antimicrobial resistance is predicted [35]. In this context, the shared production of native fish species and O. niloticus could pose a risk of transmitting antimicrobial-resistant Lactococcus spp. strains, or it could enable L. petauri isolates from O. niloticus to acquire resistance genes in this production environment, resulting in an unsatisfactory therapeutic approach during disease outbreaks. Therefore, monitoring of antimicrobial resistance in Lactococcus spp. strains becomes essential.
Sun et al. [52] reported that acquired resistance in microorganisms occurs for two reasons: the natural resistance of bacteria to certain antimicrobials and acquired resistance due to continuous exposure to antimicrobials. Once the bacteria becomes resistant, this resistance can be transferred to the other bacterial species through horizontal gene transfer [12]. Furthermore, some L. garvieae strains carry these antimicrobial resistance genes on transferable R plasmids [38]. The acquisition and transfer of antimicrobial resistance genes have been considered to be responsible for the spread and distribution of antimicrobial resistance [18]. Previous studies indicate a high prevalence of antimicrobial resistance genes in Lactococcus spp. isolates from O. mykiss [15,18,38]. There is no description of the detection of resistance genes in Lactococcus spp. strains from Brazilian fishes. However, given the higher percentage of multi-resistant isolates, future studies should be conducted to identify resistance genes, particularly those encoding antimicrobial resistance, using genomic tools.
In Brazil, only florfenicol and oxytetracycline are approved antimicrobial agents for use in aquaculture [13]. Both antimicrobials act against Gram-negative and Gram-positive bacteria; they are bacteriostatic drugs that work by binding to bacterial ribosomal subunits and inhibiting protein synthesis [12]. However, neither of these antimicrobials has been evaluated for their therapeutic efficacy in fish either naturally or experimentally infected with Lactococcus spp. in Brazil. Nevertheless, the administration of oxytetracycline in O. mykiss in Greece was reported to be unsatisfactory in both prophylactic and therapeutic treatments [53]. The circulation of florfenicol- and oxytetracycline-resistant strains in Brazilian fish farms could become a significant health issue when producing native species. The oral administration of amoxicillin, erythromycin, and flumequine did not yield significant results in the treatment of O. mykiss and D. labrax with lactococcosis [6,53]. However, based on the antimicrobial susceptibility tests from our study, amoxicillin and neomycin could be tested for their therapeutic efficacy against piscine lactococcosis in Brazil.

5. Conclusions

In this study, we calculated the pECVs for L. garvieae strains in Brazil. The antimicrobial resistance profiles of L. garvieae, L. formosensis, and L. petauri were assessed, being observed an interspecies variation. A higher percentage of resistance to various antimicrobials was observed among the evaluated isolates, especially for L. petauri, including multidrug-resistant strains. Resistance to florfenicol and oxytetracycline has been observed among Lactococcus spp. strains obtained from native fish in Brazil, which raises concerns about improper use of these drugs in the production chain of these fish species in the country. This is quite different from what has been observed in O. niloticus farms in Brazil, thus making it essential to monitor the susceptibility of the isolates and raise awareness among producers about the correct use of antibiotics.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms12112327/s1, Figure S1: Alluvial plot demonstrating the association of the host with antimicrobial susceptibility or resistance to florfenicol (FLO) and oxytetracycline (OXY) in L. formosensis (A), L. garvieae (B), and L. petauri (C) strains; Figure S2: Histograms of the inhibition zone for Lactococcus garvieae strains against amoxicillin (AMO), erythromycin (ERY), florfenicol (FLO), neomycin (NEO), norfloxacin (NOR), oxytetracycline (OXY), and trimethoprim/sulfamethoxazole (SXT); Table S1: Inhibition zones diameters (mm) of antimicrobial agents against Lactococcus spp. strains determined using disk diffusion susceptibility assay and MAR index calculated per isolate; Table S2: Inhibition zones diameters (mm) of antimicrobial agents against Lactococcus garvieae strains used to satisfy the minimum requirements of the NRI method.

Author Contributions

Conceptualization: A.E.C.d.R., A.C.C.B., H.C.M., H.C.P.F. and G.C.T.; Methodology: A.E.C.d.R., A.C.C.B., H.C.M., C.R.M.d.S.M., J.M.T., H.C.P.F. and G.C.T.; Formal analysis: A.E.C.d.R., A.C.C.B. and H.C.M.; Investigation: A.E.C.d.R., A.C.C.B., H.C.M., C.R.M.d.S.M., L.F.F.N., F.P., S.U.G., C.A.G.L., H.C.P.F. and G.C.T.; Resources: F.P., S.U.G., C.A.G.L., H.C.P.F. and G.C.T.; Data curation: L.F.F.N. and G.C.T.; Writing—original draft preparation, A.E.C.d.R. and G.C.T.; Writing—review and editing, A.E.C.d.R., A.C.C.B., H.C.M., C.R.M.d.S.M., J.M.T., L.F.F.N., F.P., S.U.G., C.A.G.L., H.C.P.F. and G.C.T.; Visualization: G.C.T.; Supervision: S.U.G., H.C.P.F. and G.C.T.; Project administration: G.C.T.; Funding acquisition: H.C.P.F. and G.C.T. All authors have read and agreed to the published version of the manuscript.

Funding

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES) through the PROCAD/Amazônia (grant number 88881.200614/2018-01), PDPG-CAPES, Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG, grant numbers APQ-01227-22, APQ-04309-22, and PPM-00779-18), and Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM, grant number 01.02.016301.03071/2022-11).

Data Availability Statement

The gyrB gene sequences of the Lactococcus spp. strains isolated from the native Brazilian fish species were included in the NCBI database as follows: L. formosensis—167/23-09: PQ529765; L. garvieae—LG114-23: PQ529769, LG116-23: PQ529771, LG119-24: PQ529773; L. petauri—167/23-03: PQ529760, 167/23-04: PQ529761, 167/23-05: PQ529762, 167/23-07: PQ529763, 167/23-08: PQ529764, 167/23-10: PQ529766, LG117-23: PQ529772.

Acknowledgments

The authors gratefully acknowledge the support provided by Maria José Tavares Ranzani-Paiva for conducting this study.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Altinok, I.; Ozturk, R.C.; Ture, M. NGS Analysis Revealed That Lactococcus garvieae Lg-Per Was Lactococcus petauri in Türkiye. J. Fish Dis. 2022, 45, 1839–1843. [Google Scholar] [CrossRef] [PubMed]
  2. Barbanti, A.C.C.; do Rosário, A.E.C.; da Silva Maia, C.R.M.; Rocha, V.P.; Costa, H.L.; Trindade, J.M.; Nogueira, L.F.F.; Rosa, J.C.C.; Ranzani-Paiva, M.J.T.; Pilarski, F.; et al. Genetic Characterization of Lactococcosis-Causing Bacteria Isolated from Brazilian Native Fish Species. Aquaculture 2024, 593, 741305. [Google Scholar] [CrossRef]
  3. Bondavalli, F.; Colussi, S.; Pastorino, P.; Zanoli, A.; Bezzo Llufrio, T.; Fernández-Garayzábal, J.F.; Acutis, P.L.; Prearo, M. First Report of Lactococcus petauri in the Pumpkinseed (Lepomis gibbosus) from Candia Lake (Northwestern Italy). Fishes 2024, 9, 117. [Google Scholar] [CrossRef]
  4. Khoo, L.H.; Austin, F.W.; Quiniou, S.M.A.; Gaunt, P.S.; Riecke, D.K.; Jacobs, A.M.; Meals, K.O.; Dunn, A.W.; Griffin, M.J. Lactococcosis in Silver Carp. J. Aquat. Anim. Health 2014, 26, 1–8. [Google Scholar] [CrossRef] [PubMed]
  5. Abraham, T.; Yazdi, Z.; Littman, E.; Shahin, K.; Heckman, T.I.; Quijano Cardé, E.M.; Nguyen, D.T.; Hu, R.; Adkison, M.; Veek, T.; et al. Detection and Virulence of Lactococcus garvieae and L. petauri from Four Lakes in Southern California. J. Aquat. Anim. Health 2023, 35, 187–198. [Google Scholar] [CrossRef]
  6. Salogni, C.; Bertasio, C.; Accini, A.; Gibelli, L.R.; Pigoli, C.; Susini, F.; Podavini, E.; Scali, F.; Varisco, G.; Alborali, G.L. The Characterisation of Lactococcus garvieae Isolated in an Outbreak of Septicaemic Disease in Farmed Sea Bass (Dicentrarchus labrax, Linnaues 1758) in Italy. Pathogens 2024, 13, 49. [Google Scholar] [CrossRef]
  7. Neupane, S.; Rao, S.; Yan, W.-X.; Wang, P.-C.; Chen, S.-C. First Identification, Molecular Characterization, and Pathogenicity Assessment of Lactococcus garvieae Isolated from Cultured Pompano in Taiwan. J. Fish Dis. 2023, 46, 1295–1309. [Google Scholar] [CrossRef]
  8. Shahin, K.; Veek, T.; Heckman, T.I.; Littman, E.; Mukkatira, K.; Adkison, M.; Welch, T.J.; Imai, D.M.; Pastenkos, G.; Camus, A.; et al. Isolation and Characterization of Lactococcus garvieae from Rainbow Trout, Onchorhyncus mykiss, from California, USA. Transbound. Emerg. Dis. 2022, 69, 2326–2343. [Google Scholar] [CrossRef]
  9. Ortega, C.; Irgang, R.; Valladares-Carranza, B.; Collarte, C.; Avendaño-Herrera, R. First Identification and Characterization of Lactococcus garvieae Isolated from Rainbow Trout (Oncorhynchus mykiss) Cultured in Mexico. Animals 2020, 10, 1609. [Google Scholar] [CrossRef]
  10. Egger, R.C.; Rosa, J.C.C.; Resende, L.F.L.; de Pádua, S.B.; de Oliveira Barbosa, F.; Zerbini, M.T.; Tavares, G.C.; Figueiredo, H.C.P. Emerging Fish Pathogens Lactococcus petauri and L. garvieae in Nile Tilapia (Oreochromis niloticus) Farmed in Brazil. Aquaculture 2023, 565, 739093. [Google Scholar] [CrossRef]
  11. de Gazal, L.E.S.; de Brito, K.C.T.; Kobayashi, R.K.T.; Nakazato, G.; Cavalli, L.S.; Otutumi, L.K.; de Brito, B.G. Antimicrobials and Resistant Bacteria in Global Fish Farming and the Possible Risk for Public Health. Arq. Inst. Biol. 2020, 87, e0362019. [Google Scholar] [CrossRef]
  12. Bondad-Reantaso, M.G.; MacKinnon, B.; Karunasagar, I.; Fridman, S.; Alday-Sanz, V.; Brun, E.; Le Groumellec, M.; Li, A.; Surachetpong, W.; Karunasagar, I.; et al. Review of Alternatives to Antibiotic Use in Aquaculture. Rev. Aquac. 2023, 15, 1421–1451. [Google Scholar] [CrossRef]
  13. Leal, C.A.G.; Silva, B.A.; Colombo, S.A. Susceptibility Profile and Epidemiological Cut-Off Values Are Influenced by Serotype in Fish Pathogenic Streptococcus agalactiae. Antibiotics 2023, 12, 1726. [Google Scholar] [CrossRef] [PubMed]
  14. Duman, M.; Buyukekiz, A.G.; Saticioglu, I.B.; Cengiz, M.; Sahinturk, P.; Altun, S. Epidemiology, Genotypic Diversity, and Antimicrobial Resistance of Lactococcus garvieae in Farmed Rainbow Trout (Oncorhynchus mykiss). Iran. J. Fish. Sci. 2020, 19, 1–18. [Google Scholar]
  15. Raissy, M.; Moumeni, M. Detection of Antibiotic Resistance Genes in Some Lactococcus garvieae Strains Isolated from Infected Rainbow Trout. Iran. J. Fish. Sci. 2016, 15, 221–229. [Google Scholar]
  16. Monteiro, S.H.; Francisco, J.G.; Andrade, G.C.R.M.; Botelho, R.G.; Figueiredo, L.A.; Tornisielo, V.L. Study of Spatial and Temporal Distribution of Antimicrobial in Water and Sediments from Caging Fish Farms by On-Line SPE-LC-MS/MS. J. Environ. Sci. Health Part B 2016, 51, 634–643. [Google Scholar] [CrossRef]
  17. Leal, C.A.G. Resistência a Antimicrobianos Na Piscicultura. Panor. Aquic. 2022, 31, 38–47. [Google Scholar]
  18. Öztürk, R.Ç.; Ustaoglu, D.; Ture, M.; Bondavalli, F.; Colussi, S.; Pastorino, P.; Vela, A.I.; Kotzamanidis, C.; Fernandez-Garayzábal, J.F.; Bitchava, K.; et al. Epidemiological Cutoff Values and Genetic Antimicrobial Resistance of Lactococcus garvieae and L. petauri. Aquaculture 2024, 593, 741340. [Google Scholar] [CrossRef]
  19. Carvalho, G.M.; Silva, B.A.; Xavier, R.G.C.; Zanon, I.P.; Vilela, E.G.; Nicolino, R.R.; Tavares, G.C.; Silva, R.O.S. Evaluation of Disk Diffusion Method for Testing the Rifampicin, Erythromycin, and Tetracycline Susceptibility of Clostridioides (Prev. Clostridium) difficile. Anaerobe 2023, 80, 102720. [Google Scholar] [CrossRef]
  20. Sebastião, F.A.; Furlan, L.R.; Hashimoto, D.T.; Pilarski, F. Identification of Bacterial Fish Pathogens in Brazil by Direct Colony PCR and 16S RRNA Gene Sequencing. Adv. Microbiol. 2015, 05, 409. [Google Scholar] [CrossRef]
  21. Fukushima, H.C.S.; Leal, C.A.G.; Cavalcante, R.B.; Figueiredo, H.C.P.; Arijo, S.; Moriñigo, M.A.; Ishikawa, M.; Borra, R.C.; Ranzani-Paiva, M.J.T. Lactococcus garvieae Outbreaks in Brazilian Farms Lactococcosis in Pseudoplatystoma sp.—Development of an Autogenous Vaccine as a Control Strategy. J. Fish Dis. 2017, 40, 263–272. [Google Scholar] [CrossRef] [PubMed]
  22. Assis, G.B.N.; Pereira, F.L.; Zegarra, A.U.; Tavares, G.C.; Leal, C.A.; Figueiredo, H.C.P. Use of MALDI-TOF Mass Spectrometry for the Fast Identification of Gram-Positive Fish Pathogens. Front. Microbiol. 2017, 8, 1492. [Google Scholar] [CrossRef] [PubMed]
  23. Tavares, G.C.; de Queiroz, G.A.; Assis, G.B.N.; Leibowitz, M.P.; Teixeira, J.P.; Figueiredo, H.C.P.; Leal, C.A.G. Disease Outbreaks in Farmed Amazon Catfish (Leiarius marmoratus x Pseudoplatystoma corruscans) Caused by Streptococcus agalactiae, S. iniae, and S. dysgalactiae. Aquaculture 2018, 495, 384–392. [Google Scholar] [CrossRef]
  24. do Rosário, A.E.C.; Henrique, M.C.; da Costa, É.J.C.; Barbanti, A.C.C.; Tavares, G.C. Surtos de Bacteriose Em Juvenis de Pirarucu (Arapaima gigas) Provevientes de Pisciculturas Amazônicas e Avaliação Da Sensibilidade de Aeromonas jandaei a Antimicrobianos. In Enfermidades Parasitárias e Bacterianas na Piscicultura Brasileira: Insights e Perspectivas; da Cruz, M.G., da Castro, J.S., Jerônimo, G.T., Eds.; i-EDUCAM: São Luís, Brazil, 2023; pp. 33–46. [Google Scholar]
  25. Ferrario, C.; Ricci, G.; Milani, C.; Lugli, G.A.; Ventura, M.; Eraclio, G.; Borgo, F.; Fortina, M.G. Lactococcus garvieae: Where Is It From? A First Approach to Explore the Evolutionary History of This Emerging Pathogen. PLoS ONE 2013, 8, e84796. [Google Scholar] [CrossRef]
  26. Miller, R.A. VET03: Methods for Antimicrobial Broth Dilution and Disk Diffusion Susceptibility Testing of Bacteria Isolated from Aquatic Animals; Clinical and Laboratory Standards Institute: Malvern, PA, USA, 2020. [Google Scholar]
  27. Smith, P.; Finnegan, W.; Ngo, T.; Kronvall, G. Influence of Incubation Temperature and Time on the Precision of MIC and Disc Diffusion Antimicrobial Susceptibility Test Data. Aquaculture 2018, 490, 19–24. [Google Scholar] [CrossRef]
  28. Kronvall, G.; Kahlmeter, G.; Myhre, E.; Galas, M.F. A New Method for Normalized Interpretation of Antimicrobial Resistance from Disk Test Results for Comparative Purposes. Clin. Microbiol. Infect. 2003, 9, 120–132. [Google Scholar] [CrossRef]
  29. Silley, P. Susceptibility testing methods, resistance and breakpoints: What do these terms really mean? Rev. Sci. Tech. Off. Int. Épizoot. 2012, 31, 33–41. [Google Scholar] [CrossRef]
  30. Smith, P. Eight Rules for Improving the Quality of Papers on the Antimicrobial Susceptibility of Bacteria Isolated from Aquatic Animals. Dis. Aquat. Organ. 2020, 139, 87–92. [Google Scholar] [CrossRef]
  31. Smith, P.; Christofilogiannis, P. Application of Normalised Resistance Interpretation to the Detection of Multiple Low-Level Resistance in Strains of Vibrio anguillarum Obtained from Greek Fish Farms. Aquaculture 2007, 272, 223–230. [Google Scholar] [CrossRef]
  32. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2024. [Google Scholar]
  33. Mauri, M.; Elli, T.; Caviglia, G.; Uboldi, G.; Azzi, M. RAWGraphs: A Visualisation Platform to Create Open Outputs. In Proceedings of the 12th Biannual Conference on Italian SIGCHI Chapter, Cagliari, Italy, 18–20 September 2017; Association for Computing Machinery: New York, NY, USA, 2017. [Google Scholar]
  34. Schwarz, S.; Silley, P.; Simjee, S.; Woodford, N.; van Duijkeren, E.; Johnson, A.P.; Gaastra, W. Assessing the Antimicrobial Susceptibility of Bacteria Obtained from Animals. Vet. Microbiol. 2010, 141, 601–604. [Google Scholar] [CrossRef]
  35. Krumperman, P.H. Multiple Antibiotic Resistance Indexing of Escherichia coli to Identify High-Risk Sources of Fecal Contamination of Foods. Appl. Environ. Microbiol. 1983, 46, 165–170. [Google Scholar] [CrossRef] [PubMed]
  36. Murray, C.J.L.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Robles Aguilar, G.; Gray, A.; Han, C.; Bisignano, C.; Rao, P.; Wool, E.; et al. Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef] [PubMed]
  37. McEwen, S.A.; Collignon, P.J. Antimicrobial Resistance: A One Health Perspective. Microbiol. Spectr. 2018, 6. [Google Scholar] [CrossRef] [PubMed]
  38. Torres-Corral, Y.; Santos, Y. Predicting Antimicrobial Resistance of Lactococcus garvieae: PCR Detection of Resistance Genes versus MALDI-TOF Protein Profiling. Aquaculture 2022, 553, 738098. [Google Scholar] [CrossRef]
  39. Altan, E.; Korun, J. Lactococcus garvieae Isolates from Rainbow Trout (Oncorhynchus mykiss, W.) Compared by PLG and SA1B10 PCR Primer Pairs. J. Ilm. Platax 2021, 9, 18–28. [Google Scholar] [CrossRef]
  40. Kawanishi, M.; Kojima, A.; Ishihara, K.; Esaki, H.; Kijima, M.; Takahashi, T.; Suzuki, S.; Tamura, Y. Drug Resistance and Pulsed-field Gel Electrophoresis Patterns of Lactococcus garvieae Isolates from Cultured Seriola (Yellowtail, Amberjack and Kingfish) in Japan. Lett. Appl. Microbiol. 2005, 40, 322–328. [Google Scholar] [CrossRef]
  41. Lim, F.H.; Jenkins, D.R. Native Valve Endocarditis Caused by Lactococcus garvieae: An Emerging Human Pathogen. BMJ Case Rep. 2017, 2017, bcr2017220116. [Google Scholar] [CrossRef]
  42. Korun, J.; Altan, E.; Teker, S.; Ulutaş, A. A Study on the Antimicrobial Resistance of Lactococcus garvieae. Acta Aquat. 2021, 8, 98–102. [Google Scholar] [CrossRef]
  43. Sezgin, S.S.; Yılmaz, M.; Arslan, T.; Kubilay, A. Current Antibiotic Sensitivity of Lactococcus garvieae in Rainbow Trout (Oncorhynchus mykiss) Farms from Southwestern Turkey. J. Agric. Sci. 2023, 29, 630–642. [Google Scholar] [CrossRef]
  44. Chang, P.H.; Lin, C.W.; Lee, Y.C. Lactococcus garvieae Infection of Cultured Rainbow Trout, Oncorhynchus mykiss, in Taiwan and Associated Biophysical Characteristics and Histopathology. Bull. Eur. Assoc. Fish Pathol. 2002, 22, 319–327. [Google Scholar]
  45. Majeed, S.; De Silva, L.A.D.S.; Kumarage, P.M.; Heo, G.J. Characterization of Pathogenic Lactococcus garvieae Isolated from Farmed Mullet (Mugil cephalus). Vet. Integr. Sci. 2025, 23, 1–17. [Google Scholar] [CrossRef]
  46. Ture, M.; Boran, H. Phenotypic and Genotypic Antimicrobial Resistance of Lactococcus sp. Strains Isolated from Rainbow Trout (Oncorhynchus mykiss). Bull. Vet. Inst. Pulawy 2015, 59, 37–42. [Google Scholar] [CrossRef]
  47. Vela, A.I.; del Mar Blanco, M.; Colussi, S.; Kotzamanidis, C.; Prearo, M.; Altinok, I.; Acutis, P.L.; Volpatti, D.; Alba, P.; Feltrin, F.; et al. The Association of Lactococcus petauri with Lactococcosis Is Older than Expected. Aquaculture 2024, 578, 740057. [Google Scholar] [CrossRef]
  48. Chan, Y.-X.; Cao, H.; Jiang, S.; Li, X.; Fung, K.-K.; Lee, C.-H.; Sridhar, S.; Chen, J.H.-K.; Ho, P.-L. Genomic Investigation of Lactococcus formosensis, Lactococcus garvieae, and Lactococcus petauri Reveals Differences in Species Distribution by Human and Animal Sources. Microbiol. Spectr. 2024, 12, e00541-24. [Google Scholar] [CrossRef] [PubMed]
  49. Heckman, T.I.; Yazdi, Z.; Older, C.E.; Griffin, M.J.; Waldbieser, G.C.; Chow, A.M.; Silva, I.M.; Anenson, K.M.; García, J.C.; LaFrentz, B.R.; et al. Redefining Piscine Lactococcosis. Appl. Environ. Microbiol. 2024, 90, e02349-23. [Google Scholar] [CrossRef]
  50. Lin, Y.; Han, J.; Barkema, H.W.; Wang, Y.; Gao, J.; Kastelic, J.P.; Han, B.; Qin, S.; Deng, Z. Comparative Genomic Analyses of Lactococcus garvieae Isolated from Bovine Mastitis in China. Microbiol. Spectr. 2023, 11, e02995-22. [Google Scholar] [CrossRef]
  51. Oliveira, T.F.; Leibowitz, M.P.; Leal, C.A.G. Local Epidemiological Cutoff Values and Antimicrobial Susceptibility Profile for Brazilian Francisella orientalis Isolates. Aquaculture 2022, 553, 738054. [Google Scholar] [CrossRef]
  52. Sun, K.; Wang, H.; Zhang, M.; Xiao, Z.; Sun, L. Genetic Mechanisms of Multi-Antimicrobial Resistance in a Pathogenic Edwardsiella tarda Strain. Aquaculture 2009, 289, 134–139. [Google Scholar] [CrossRef]
  53. Savvidis, G.K.; Anatoliotis, C.; Kanaki, Z.; Vafeas, G. Epizootic Outbreaks of Lactococcosis Disease in Rainbow Trout, Oncorhynchus mykiss (Walbaum), Culture in Greece. Bull. Eur. Assoc. Fish Pathol. 2007, 27, 223–228. [Google Scholar]
Figure 1. Disk diffusion scatter plots for antimicrobials versus diameters of inhibition zones for the six L. formosensis, 17 L. garvieae, and 24 L. petauri strains evaluated.
Figure 1. Disk diffusion scatter plots for antimicrobials versus diameters of inhibition zones for the six L. formosensis, 17 L. garvieae, and 24 L. petauri strains evaluated.
Microorganisms 12 02327 g001
Figure 2. Multiple antibiotic resistance (MAR) index box plot of Lactococcus spp. strains isolated from native Brazilian fish species.
Figure 2. Multiple antibiotic resistance (MAR) index box plot of Lactococcus spp. strains isolated from native Brazilian fish species.
Microorganisms 12 02327 g002
Table 1. Metadata of the 47 strains of lactococcosis-causing bacteria isolated from the native Brazilian fish species.
Table 1. Metadata of the 47 strains of lactococcosis-causing bacteria isolated from the native Brazilian fish species.
IsolateSpeciesHostOriginTissueYearStateGenbank No.Reference
167/23-02L. formosensisArapaima gigasFarmedBrain2023BAPP591851[2]
167/23-06L. formosensisArapaima gigasFarmedBrain2023BAPP591852[2]
167/23-09L. formosensisArapaima gigasFarmedKidney2023BAPQ529765This study
AM-LG05L. formosensisColossoma macropomumFarmedIntestine2022AMPP591853[2]
52MSL. formosensisPseudoplatystoma fasciatumFarmedBrain2012MSPP591850[20]
LG91-23L. formosensisPseudoplatystoma sp.FarmedBrain2023MGPP591854[2]
CRBP53L. garvieaeArapaima gigasFarmedIntestine2023AMPP591857[2]
CRBP54L. garvieaeArapaima gigasFarmedIntestine2023AMPP591858[2]
CRBP138L. garvieaeArapaima gigasFarmedIntestine2023AMPP591859[2]
CRBP144L. garvieaeArapaima gigasFarmedIntestine2023AMPP591860[2]
PA-LG01L. garvieaeArapaima gigasFarmedBrain2018PAPP591868[24]
LG88-23L. garvieaeBrycon amazonicusFarmedBrain2023MGPP591866[2]
LG89-23L. garvieaeBrycon amazonicusFarmedKidney2023MGPP591867[2]
LG116-23L. garvieaeCichla sp.WildBrain2023MGPQ529771This study
LG63-21L. garvieaeHoplias macrophtalmusFarmedKidney2021MGPP591864[2]
LG114-23L. garvieaeHoplias malabaricusWildBrain2023AMPQ529769This study
LG10-14L. garvieaeLophiosilurus alexandriFarmedBrain2014MGPP591862[22]
LG66-22L. garvieaePhractocephalus hemioliopterusFarmedKidney2022MGPP591865[2]
LG09-14L. garvieaePseudoplatystoma corruscansFarmedKidney2014SPPP591861[22]
LG23-16L. garvieaePseudoplatystoma corruscansFarmedBrain2016SPPP591863[23]
177L. garvieaePseudoplatystoma fasciatumFarmedBrain2012MSPP591856[21]
31MSL. garvieaePseudoplatystoma fasciatumFarmedKidney2012MSPP591855[20]
LG119-24L. garvieaePseudoplatystoma sp.FarmedBrain2024MGPQ529773This study
167/23-03L. petauriArapaima gigasFarmedKidney2023BAPQ529760This study
167/23-04L. petauriArapaima gigasFarmedKidney2023BAPQ529761This study
167/23-05L. petauriArapaima gigasFarmedKidney2023BAPQ529762This study
167/23-07L. petauriArapaima gigasFarmedKidney2023BAPQ529763This study
167/23-08L. petauriArapaima gigasFarmedKidney2023BAPQ529764This study
167/23-10L. petauriArapaima gigasFarmedSpleen2023BAPQ529766This study
CRBT89L. petauriArapaima gigasFarmedIntestine2023AMPP591879[2]
CRBT98L. petauriArapaima gigasFarmedIntestine2023AMPP591880[2]
CRBP146L. petauriArapaima gigasFarmedIntestine2023AMPP591878[2]
AM-LG07L. petauriBrycon amazonicusFarmedBrain2022AMPP591876[2]
AM-LG08L. petauriBrycon amazonicusFarmedBrain2022AMPP591877[2]
AM-LG02L. petauriColossoma macropomumFarmedIntestine2020AMPP591874[2]
AM-LG03L. petauriColossoma macropomumFarmedIntestine2022AMPP591875[2]
LG03-18L. petauriPseudoplatystoma corruscansFarmedBrain2018MGPP591881[2]
14MSL. petauriPseudoplatystoma fasciatumFarmedKidney2012MSPP591869[20]
176L. petauriPseudoplatystoma fasciatumFarmedBrain2012MSPP591873[21]
86L. petauriPseudoplatystoma sp.FarmedBrain2012MSPP591870[21]
89/2L. petauriPseudoplatystoma sp.FarmedBrain2012MSPP591871[21]
93L. petauriPseudoplatystoma sp.FarmedBrain2012MSPP591872[21]
LG86-23L. petauriPseudoplatystoma sp.FarmedKidney2023MGPP591882[2]
LG94-23L. petauriPseudoplatystoma sp.FarmedBrain2023MGPP591883[2]
LG104-23L. petauriPseudoplatystoma sp.FarmedBrain2023MGPP591884[2]
LG106-23L. petauriPseudoplatystoma sp.FarmedKidney2023MGPP591885[2]
LG117-23L. petauriPseudoplatystoma sp.FarmedKidney2023MGPQ529772This study
AM: Amazonas; BA: Bahia; MS: Mato Grosso do Sul; MG: Minas Gerais; PA: Pará; SP: São Paulo.
Table 2. Minimum and maximum values, mean, and standard deviation of the inhibition zone diameters, epidemiological cutoff values, and wild type/non-wild type (WT/NWT) percentual for Lactococcus spp. and quality control strains in the antimicrobial susceptibility analysis.
Table 2. Minimum and maximum values, mean, and standard deviation of the inhibition zone diameters, epidemiological cutoff values, and wild type/non-wild type (WT/NWT) percentual for Lactococcus spp. and quality control strains in the antimicrobial susceptibility analysis.
AntimicrobialsMinimum ValueMaximum ValueMean ± SDECV (mm)WT (%)NWT * (%)
Lactococcus formosensis a
Amoxicillin192723.2 ± 2.7---
Erythromycin203025.7 ± 3.7---
Florfenicol62822.3 ± 7.8--16.7
Neomycin101714.9 ± 2.4---
Norfloxacin666.0 ± 0.0--100
Oxytetracycline6279.5 ± 7.5--66.7
Trimethoprim-sulfametoxazole666.0 ± 0.0--100
Lactococcus garvieae b
Amoxicillin182821.4 ± 2.2≥111000
Erythromycin163124.7 ± 3.7≥161000
Florfenicol62920.9 ± 4.4≥1294.45.6
Neomycin101915.1 ± 2.7≥71000
Norfloxacin6199.0 ± 4.0 --47
Oxytetracycline62716.5 ± 7.3 ≥10 72.227.8
Trimethoprim-sulfametoxazole6197.2 ± 3.4 --88.2
Lactococcus petauri c
Amoxicillin152620.5 ± 3.0≥1695.84.2
Erythromycin63122.4 ± 7.1≥2366.733.3
Florfenicol62919.5 ± 6.9≥2162.537.5
Neomycin101914.2 ± 2.2≥91000
Norfloxacin6148.6 ± 2.9≥1316.783.3
Oxytetracycline62613.6 ± 7.5≥2316.783.3
Trimethoprim-sulfametoxazole6146.3 ± 1.4--95.8
Escherichia coli ATCC 25922 d
Amoxicillin141915.8 ± 2.4---
Erythromycin121814.6 ± 2.8---
Florfenicol192823.5 ± 4.4---
Neomycin162018.0 ± 2.0---
Norfloxacin243430.6 ± 5.7---
Oxytetracycline192723.2 ± 3.3---
Trimethoprim-sulfametoxazole252625.5 ± 0.7---
Aeromonas salmonicida subsp. salmonicida ATCC 33658 d
Amoxicillin243027.4 ± 3.1---
Erythromycin192220.7 ± 1.5---
Florfenicol323634.2 ± 1.7---
Neomycin122017.3 ± 4.6---
Norfloxacin213729.6 ± 8.0---
Oxytetracycline293229.7 ± 1.5---
Trimethoprim-sulfametoxazole242625.0 ± 1.4---
a ECV undetermined; b pECV determined in this study; c pECV determined in Egger et al. [10]; d Quality control strains; * Regardless of the bacterial species, bacteria that did not present an inhibition zone and did not have a defined epidemiological cutoff value (ECV) were considered NS for the antimicrobials [31].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rosário, A.E.C.d.; Barbanti, A.C.C.; Matos, H.C.; Maia, C.R.M.d.S.; Trindade, J.M.; Nogueira, L.F.F.; Pilarski, F.; Gallani, S.U.; Leal, C.A.G.; Figueiredo, H.C.P.; et al. Antimicrobial Resistance in Lactococcus spp. Isolated from Native Brazilian Fish Species: A Growing Challenge for Aquaculture. Microorganisms 2024, 12, 2327. https://doi.org/10.3390/microorganisms12112327

AMA Style

Rosário AECd, Barbanti ACC, Matos HC, Maia CRMdS, Trindade JM, Nogueira LFF, Pilarski F, Gallani SU, Leal CAG, Figueiredo HCP, et al. Antimicrobial Resistance in Lactococcus spp. Isolated from Native Brazilian Fish Species: A Growing Challenge for Aquaculture. Microorganisms. 2024; 12(11):2327. https://doi.org/10.3390/microorganisms12112327

Chicago/Turabian Style

Rosário, Angélica Emanuely Costa do, Angelo Carlo Chaparro Barbanti, Helena Caldeira Matos, Cynthia Rafaela Monteiro da Silva Maia, Júlia Miranda Trindade, Luiz Fagner Ferreira Nogueira, Fabiana Pilarski, Silvia Umeda Gallani, Carlos Augusto Gomes Leal, Henrique César Pereira Figueiredo, and et al. 2024. "Antimicrobial Resistance in Lactococcus spp. Isolated from Native Brazilian Fish Species: A Growing Challenge for Aquaculture" Microorganisms 12, no. 11: 2327. https://doi.org/10.3390/microorganisms12112327

APA Style

Rosário, A. E. C. d., Barbanti, A. C. C., Matos, H. C., Maia, C. R. M. d. S., Trindade, J. M., Nogueira, L. F. F., Pilarski, F., Gallani, S. U., Leal, C. A. G., Figueiredo, H. C. P., & Tavares, G. C. (2024). Antimicrobial Resistance in Lactococcus spp. Isolated from Native Brazilian Fish Species: A Growing Challenge for Aquaculture. Microorganisms, 12(11), 2327. https://doi.org/10.3390/microorganisms12112327

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop